| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.49B | $3.48B | $3.36B |
| YoY Revenue Growth % | +0.2% | +3.4% | — |
| Gross Profit | $2.54B | $2.49B | — |
| Gross Margin % | 72.8% | 71.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $872.5M | $823.3M | $916.9M |
| Operating Margin % | 25.0% | 23.7% | 27.3% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $917.9M | $863.8M | $1.04B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.08B | $932.7M | $896.8M |
| Capital Expenditures (CapEx) | $56.8M | $50.6M | $151.4M |
| Free Cash Flow (FCF) | $1.02B | $882.1M | $745.4M |
| FCF Margin % | 29.4% | 25.4% | 22.2% |
| Return on Invested Capital (ROIC %) | 30.4% | 23.1% | 22.3% |
| Cash & Short-Term Equivalents | $1.03B | $966.0M | — |
| Total Debt (Short + Long Term) | $3.55B | $3.85B | $1.26B |
| Total Stockholders' Equity | -$253.5M | -$63.7M | $2.58B |